Crohn’s disease

Share on facebook
Share on pinterest
Share on twitter
Share on email
Share on whatsapp

Treatment of Crohn’s Disease with Cannabis: An Observational Study


IMAJ – The Israel Medical Association Journal, 2011

Timna Naftali 1, Lihi Bar Lev, Doron Yablecovitch, Elisabeth Half, Fred M Konikoff

1Institute of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.

The marijuana plant cannabis is known to have therapeutic effects, including improvement of inflammatory processes. However, no report of patients using cannabis for Crohn’s disease (CD) was ever published. This groundbreaking retrospective observational study in which 30 Crohn’s patients who participated in the study were interviewed, was conducted in collaboration with the Institute of Gastroenterology and Hepatology, Meir Medical Center. was the first to participate IBD cannabis clinical study. The aim of the study was to describe the effects of cannabis use among patients with Crohn’s disease. All patients reported a positive effect on their Crohn’s disease activity and on the symptoms that characterize the disease.

STUDY POPULATION: 30 patients with Crohn’s disease (26 males, mean age 36).

STUDY PRODUCT: Erez

RESULTS:

• The average duration of cannabis use was 2.14 years. In 14/30 of the patients, the duration of cannabis use was less than a year.

Overall improvement – Of the 30 patients, 21 improved significantly after cannabis treatment.

The Harvey Bradshaw index, an index for assessing the severity of Crohn’s disease, improved from an average of 14 to 7 (P <0.001).

Decrease in drug use – Consumption of conventional drugs has been significantly reduced.

• 15 patients underwent 19 surgeries in an average period of 9 years before cannabis use, but only 2 required surgery during an average period of 3 years of cannabis use.

• No significant side effects were observed.

FULL STUDY

Have you liked our facebook page?

Common Questions

Ordering Tikun Olam Products

Proudly leading the revolution for modern Cannabis treatment

Related Topics

Epidemiological Characteristics, Safety and Efficacy of Medical Cannabis in the Elderly European Journal of Internal Medicine, 2018 Ran Abuhasira1, Lihi Bar-Lev Schleider1,2, Raphael Mechoulam3, Victor

Medical Cannabis in Parkinson Disease: Real-Life Patients’ ExperienceClinical Neuropharmacology, 2017 Yacov Balash1,2, Lihi Bar-Lev Schleider3, Amos D. Korczyn2, Herzel Shabtai1, Judith Knaani1, Alina Rosenberg4, Yehuda Baruch5, Ruth

Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders Journal of Child Neurology, 2018 Stephanie Libzon1, Lihi Bar-Lev Schleider2, Naama Saban2, Luda Levit2, Yulia

whatsapp

תודה על הגשת מועמדותך, במידה וקורות החיים ימצאו רלוונטיים ניצור קשר. בהצלחה!